Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.78 USD | +0.29% | -6.31% | -11.48% |
05-09 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
05-08 | Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.48% | 775M | |
+4.54% | 111B | |
+11.60% | 105B | |
-12.82% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.02% | 16.96B | |
+3.54% | 13.7B | |
+37.74% | 12.45B |
- Stock Market
- Equities
- RGNX Stock
- News REGENXBIO Inc.
- RBC Capital Adjusts REGENXBIO Price Target to $22 From $25, Maintains Sector Perform - Speculative Risk Rating